KR20030017543A - 치환된 옥타노일 아미드의 제조방법 - Google Patents
치환된 옥타노일 아미드의 제조방법 Download PDFInfo
- Publication number
- KR20030017543A KR20030017543A KR1020027017207A KR20027017207A KR20030017543A KR 20030017543 A KR20030017543 A KR 20030017543A KR 1020027017207 A KR1020027017207 A KR 1020027017207A KR 20027017207 A KR20027017207 A KR 20027017207A KR 20030017543 A KR20030017543 A KR 20030017543A
- Authority
- KR
- South Korea
- Prior art keywords
- alkyl
- formula
- compound
- alkoxy
- alkyloxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
- C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
- C07C247/12—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C57/42—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
Abstract
Description
Claims (12)
- a) 하기 화학식(II)의 화합물을 화학식 R5-NH2의 아민과 반응시켜 하기 화학식(III)의 화합물을 생성하고,b) 하기 화학식(III)의 화합물의 아지드기를, 필요한 경우 염형성 산을 부가하여 아민기로 환원시키고 또 화학식(I)의 화합물을 분리하는 것을 포함하는 화학식(I)의 화합물의 제조방법에 있어서,화학식(II)의 화합물은,c1) 하기 화학식(IV)의 화합물을 할로겐화제와 반응시켜 하기 화학식(VI)의 화합물을 형성하거나, 또는c2) 하기 화학식(V)의 카르복시산 또는 이 카르복시산의 염을 할로겐화제와 반응시켜 하기 화학식(VI)의 화합물을 형성하고,d) 화학식(VI)의 화합물을 알칼리 금속 또는 알칼리 토금속 수산화물 또는 알코올 존재하에서 반응시켜 하기 화학식(VII)의 화합물을 형성하며,e) 화학식(VII)의 화합물을 산 존재하에서 가수분해시켜 하기 화학식(VIII)의 화합물을 형성하고,f) 화학식(VIII)의 화합물중의 히드록시기의 수소원자를 치환하고 그를 이탈기 AO로 전환시켜 하기 화학식(IX)의 화합물을 형성하며,g) 이어 화학식(IX)의 화합물을 아지드화제와 반응시켜 하기 화학식(II)의화합물을 형성하거나, 또는h) 화학식(VIII)의 화합물을 삼차 포스핀 및 아조디카르복실레이트 존재하에서, 필요한 경우 유기 용매중에서, 아연 아지드/-비스-피리딘 착물과 직접적으로 반응시켜 화학식(II)의 화합물을 형성함으로써 제조되는 것을 특징으로하는, 화학식(I)의 화합물의 제조방법:(I)(II)(III)(IV)(V)(VI)(VII)(VIII)(IX)식중에서,R1및 R2는 독립적으로 H, C1-C6알킬, C1-C6할로겐알킬, C1-C6알콕시, C1-C6알콕시-C1-C6알킬 또는 C1-C6알콕시-C1-C6알킬옥시이고,R3은 C1-C6알킬이며,R4는 C1-C6알킬이고,R5는 C1-C6알킬, C1-C6히드록시알킬, C1-C6알콕시-C1-C6알킬, C1-C6알카노일옥시-C1-C6알킬, C1-C6아미노알킬, C1-C6알킬아미노-C1-C6알킬, C1-C6-디알킬아미노-C1-C6알킬, C1-C6알카노일아미도-C1-C6알킬, HO(O)C-C1-C6알킬, C1-C6알킬-O-(O)C-C1-C6알킬, H2N-C(O)-C1-C6알킬, C1-C6알킬-HN-C(O)-C1-C6알킬 또는 (C1-C6알킬)2N-C(O)-C1-C6알킬이며,R6은 C1-C20알킬, C3-C12시클로알킬, C3-C12시클로알킬-C1-C6알킬, C6-C10아릴 또는 C6-C10아릴-C1-C6알킬이고,X는 Cl, Br 또는 I이며, 또M은 알칼리 금속, 등가의 알칼리 토금속 또는 알코올에서 히드록시기가 제거된 잔기임.
- 제1항에 있어서, R1이 C1-C4알콕시 또는 C1-C4알콕시-C1-C4알킬옥시이고, R2는 C1-C4알콕시이며, R3은 C1-C4알킬이고, R4는 C1-C4알킬이며 또 R5는 필요에 따라 N-일치환되거나 N-디-C1-C4알킬 치환된 H2NC(O)-C1-C6알킬인 구체예를 포함하는 방법.
- 제2항에 있어서, R1이 1-메톡시프로프-3-일옥시이고 R2가 메톡시인 구체예를 포함하는 방법.
- 제2항에 있어서, R3및 R4가 각각 이소프로필인 구체예를 포함하는 방법.
- 제2항에 있어서, R5가 H2NC(O)-C1-C6알킬인 구체예를 포함하는 방법.
- 제1항에 있어서, R1은 메톡시-C2-C4알킬옥시이고, R2는 메톡시 또는 에톡시이며, R3은 C2-C4알킬이고, R4는 C2-C4알킬이며 또 R5는 H2NC(O)-C1-C6알킬인 구체예를 포함하는 방법.
- 제1항에 있어서, R1은 3-메톡시-프로프-3-일옥시이고, R2는 메톡시이며, R3및 R4는 각각 1-메틸에트-1-일이고 또 R5는 H2NC(O)-[C(CH3)2]-CH2-인 구체예를 포함하는 방법.
- 하기 화학식(X)의 화합물:(X)식중에서,R1및 R2는 서로 독립적으로 H, C1-C6알킬, C1-C6할로겐알킬, C1-C6알콕시, C1-C6알콕시-C1-C6알킬 또는 C1-C6알콕시-C1-C6알킬옥시이고,R3은 C1-C6알킬이며,R4는 C1-C6알킬이고,R5는 C1-C6알킬, C1-C6히드록시알킬, C1-C6알콕시-C1-C6알킬, C1-C6알카노일옥시 -C1-C6알킬, C1-C6아미노알킬, C1-C6알킬아미노-C1-C6알킬, C1-C6-디알킬아미노-C1-C6알킬, C1-C6알카노일아미도-C1-C6알킬, HO(O)C-C1-C6알킬, C1-C6알킬-O-(O)C-C1-C6알킬, H2N-C(O)-C1-C6알킬, C1-C6알킬-HN-C(O)-C1-C6알킬 또는 (C1-C6알킬)2N-C(O)-C1-C6알킬이며, 또R8은 수소이거나 또는 R8O는 이탈기임.
- 하기 화학식(XI)의 화합물:(XI)식중에서,X는 할로겐이고 또 R9는 화학식의 잔기이고,R1및 R2는 서로 독립적으로 H, C1-C6알킬, C1-C6할로겐알킬, C1-C6알콕시, C1-C6알콕시-C1-C6알킬 또는 C1-C6알콕시-C1-C6알킬옥시이고,R3은 C1-C6알킬이며,R4는 C1-C6알킬이고, 또R5는 C1-C6알킬, C1-C6히드록시알킬, C1-C6알콕시-C1-C6알킬, C1-C6알카노일옥시 -C1-C6알킬, C1-C6아미노알킬, C1-C6알킬아미노-C1-C6알킬, C1-C6-디알킬아미노-C1-C6알킬, C1-C6알카노일아미도-C1-C6알킬, HO(O)C-C1-C6알킬, C1-C6알킬-O-(O)C-C1-C6알킬, H2N-C(O)-C1-C6알킬, C1-C6알킬-HN-C(O)-C1-C6알킬 또는 (C1-C6알킬)2N-C(O)-C1-C6알킬임.
- 하기 화학식(XII)의 화합물:(XII)식중에서,R10은 화학식의 잔기이고,R1및 R2는 서로 독립적으로 H, C1-C6알킬, C1-C6할로겐알킬, C1-C6알콕시, C1-C6알콕시-C1-C6알킬 또는 C1-C6알콕시-C1-C6알킬옥시이고,R3은 C1-C6알킬이며,R4는 C1-C6알킬이고, 또R5는 C1-C6알킬, C1-C6히드록시알킬, C1-C6알콕시-C1-C6알킬, C1-C6알카노일옥시 -C1-C6알킬, C1-C6아미노알킬, C1-C6알킬아미노-C1-C6알킬, C1-C6-디알킬아미노-C1-C6알킬, C1-C6알카노일아미도-C1-C6알킬, HO(O)C-C1-C6알킬, C1-C6알킬-O-(O)C-C1-C6알킬, H2N-C(O)-C1-C6알킬, C1-C6알킬-HN-C(O)-C1-C6알킬 또는 (C1-C6알킬)2N-C(O)-C1-C6알킬임.
- 하기 화학식(VII)의 화합물:(VII)식중에서,M은 알칼리 금속, 등가의 알칼리 토금속 또는 알코올에서 히드록시기를 뺀 잔기이고,R1및 R2는 서로 독립적으로 H, C1-C6알킬, C1-C6할로겐알킬, C1-C6알콕시, C1-C6알콕시-C1-C6알킬 또는 C1-C6알콕시-C1-C6알킬옥시이고,R3은 C1-C6알킬이며,R4는 C1-C6알킬이고, 또R5는 C1-C6알킬, C1-C6히드록시알킬, C1-C6알콕시-C1-C6알킬, C1-C6알카노일옥시 -C1-C6알킬, C1-C6아미노알킬, C1-C6알킬아미노-C1-C6알킬, C1-C6-디알킬아미노-C1-C6알킬, C1-C6알카노일아미도-C1-C6알킬, HO(O)C-C1-C6알킬, C1-C6알킬-O-(O)C-C1-C6알킬, H2N-C(O)-C1-C6알킬, C1-C6알킬-HN-C(O)-C1-C6알킬 또는 (C1-C6알킬)2N-C(O)-C1-C6알킬임.
- 하기 화학식(XIII)의 화합물:(XIII)식중에서,R11은 알칼리 금속, 등가의 알칼리 토금속, 수소 또는 알코올에서 히드록시기를 뺀 잔기이고,R1및 R2는 서로 독립적으로 H, C1-C6알킬, C1-C6할로겐알킬, C1-C6알콕시, C1-C6알콕시-C1-C6알킬 또는 C1-C6알콕시-C1-C6알킬옥시이고,R3은 C1-C6알킬이며,R4는 C1-C6알킬이고, 또R5는 C1-C6알킬, C1-C6히드록시알킬, C1-C6알콕시-C1-C6알킬, C1-C6알카노일옥시 -C1-C6알킬, C1-C6아미노알킬, C1-C6알킬아미노-C1-C6알킬, C1-C6-디알킬아미노-C1-C6알킬, C1-C6알카노일아미도-C1-C6알킬, HO(O)C-C1-C6알킬, C1-C6알킬-O-(O)C-C1-C6알킬, H2N-C(O)-C1-C6알킬, C1-C6알킬-HN-C(O)-C1-C6알킬 또는 (C1-C6알킬)2N-C(O)-C1-C6알킬임.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1329/00 | 2000-07-05 | ||
CH13292000 | 2000-07-05 | ||
CH2450/00 | 2000-12-15 | ||
CH24502000 | 2000-12-15 | ||
PCT/CH2001/000399 WO2002002508A1 (en) | 2000-07-05 | 2001-06-26 | Process for the preparation of substituted octanoyl amides |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030017543A true KR20030017543A (ko) | 2003-03-03 |
KR100690471B1 KR100690471B1 (ko) | 2007-03-09 |
Family
ID=25738979
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020027017207A KR100690471B1 (ko) | 2000-07-05 | 2001-06-26 | 치환된 옥타노일 아미드의 제조방법 |
Country Status (24)
Country | Link |
---|---|
US (1) | US6730798B2 (ko) |
EP (1) | EP1296935B1 (ko) |
JP (1) | JP4900755B2 (ko) |
KR (1) | KR100690471B1 (ko) |
CN (1) | CN100482636C (ko) |
AR (1) | AR029564A1 (ko) |
AT (1) | ATE426592T1 (ko) |
AU (2) | AU2001273763B2 (ko) |
BR (1) | BR0112362B1 (ko) |
CA (1) | CA2414847C (ko) |
CY (1) | CY1109110T1 (ko) |
DE (1) | DE60138099D1 (ko) |
DK (1) | DK1296935T3 (ko) |
ES (1) | ES2322547T3 (ko) |
HK (1) | HK1093201A1 (ko) |
HU (1) | HU228526B1 (ko) |
IL (4) | IL153717A0 (ko) |
MX (1) | MXPA02012628A (ko) |
NO (1) | NO328105B1 (ko) |
NZ (1) | NZ523088A (ko) |
PL (1) | PL212898B1 (ko) |
PT (1) | PT1296935E (ko) |
TW (1) | TWI289551B (ko) |
WO (1) | WO2002002508A1 (ko) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060154926A1 (en) * | 2002-06-11 | 2006-07-13 | Elan Pharmaceuticals, Inc. | Methods of treating alzheimer's disease using aryl alkanoic acid amides |
GB0419361D0 (en) | 2004-08-31 | 2004-10-06 | Novartis Ag | Organic compounds |
GB0511686D0 (en) | 2005-06-08 | 2005-07-13 | Novartis Ag | Organic compounds |
RU2470018C2 (ru) * | 2005-07-11 | 2012-12-20 | Новартис Аг | Новые производные пирокатехина |
GB0519764D0 (en) | 2005-09-28 | 2005-11-09 | Novartis Ag | Organic compounds |
GB2431649A (en) * | 2005-10-25 | 2007-05-02 | Novartis Ag | Alternative synthesis of aryl-octanoyl amide compounds |
GB2431645A (en) * | 2005-10-25 | 2007-05-02 | Novartis Ag | Alternative synthesis of aryl-octanoyl amide compounds |
DE102005052195A1 (de) | 2005-10-28 | 2007-05-03 | Reuter Chemischer Apparatebau Kg | Verfahren zur Herstellung von chiralen Octensäurederivaten |
GB0605688D0 (en) | 2006-03-21 | 2006-05-03 | Novartis Ag | Organic compounds |
PE20081157A1 (es) * | 2006-11-07 | 2008-09-26 | Novartis Ag | Forma cristalina de hemifumarato de alisquireno |
BRPI0718701A2 (pt) * | 2006-11-09 | 2013-12-31 | Novartis Ag | Sal de alisquireno com ácido orótico |
EP1958666A1 (en) | 2007-02-13 | 2008-08-20 | Speedel Experimenta AG | Heterocyclic-substituted alkanamides as therapeutic compounds |
DE102007049039A1 (de) | 2007-10-11 | 2009-04-16 | Reuter Chemischer Apparatebau Kg | Verfahren zur Herstellung von 8-Hydrazino-8-Aryl-Octanoylderivaten und deren Verwendung |
EP2220031A1 (en) * | 2007-11-13 | 2010-08-25 | Teva Pharmaceutical Industries Ltd. | Polymorphic forms of aliskiren hemifumarate and process for preparation thereof |
EP2062874B1 (en) | 2007-11-20 | 2014-12-17 | KRKA, tovarna zdravil, d.d., Novo mesto | Process and intermediates for the preparation of aliskiren |
WO2009143423A1 (en) * | 2008-05-23 | 2009-11-26 | Teva Pharmaceutical Industries Ltd. | Aliskiren monofumarate and processes for preparation thereof |
EP2189442B1 (en) | 2008-11-20 | 2014-10-01 | Krka Tovarna Zdravil, D.D., Novo Mesto | Process and intermediates for the preparation of aliskiren |
WO2010089105A2 (en) | 2009-02-05 | 2010-08-12 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Moisture-activated granulation process |
EP2273990A2 (en) * | 2009-02-05 | 2011-01-19 | Teva Pharmaceutical Industries Ltd. | Solid state forms of aliskiren compounds |
WO2011028919A2 (en) | 2009-09-03 | 2011-03-10 | Teva Pharmaceutical Industries Ltd. | Solid forms of aliskiren hemifumarate and processes for preparation thereof |
WO2011051853A1 (en) | 2009-10-29 | 2011-05-05 | CarboDesign LLC | Manufacturing process for preparing enaniomerically pure 8- aryloctanoic acid derivatives such as aliskiren |
US20110113995A1 (en) * | 2009-11-13 | 2011-05-19 | Lindsay Corporation | Method and apparatus for planting and irrigation |
WO2011148392A1 (en) * | 2010-05-28 | 2011-12-01 | Msn Laboratories Limited | Process for the preparation of (2s,4s,5s,7s)-n-(2-carbamyl-2- methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-[4-methoxy-3-(3- methoxypropoxy)phenyl]-octanamide hemifumarate and its intermediates thereof |
WO2012052829A1 (en) | 2010-10-19 | 2012-04-26 | Matrix Laboratories Ltd | Synthesis of aliskiren |
ITMI20110893A1 (it) * | 2011-05-19 | 2012-11-20 | Chemelectiva S R L | Processi ed intermedi per la sintesi di aliskiren |
EP2551260A1 (en) | 2011-07-28 | 2013-01-30 | Chemo Ibérica, S.A. | Chemical process for opening ring compounds |
US8703976B2 (en) | 2011-10-02 | 2014-04-22 | Milan Soukup | Manufacturing process for 8-aryloctanoic acids such as Aliskiren |
WO2013118138A1 (en) | 2011-12-13 | 2013-08-15 | Laboratories Ltd Mylan | Novel process for the preparation of renin inhibitors |
US9090537B2 (en) | 2012-02-17 | 2015-07-28 | Mylan Laboratories Limited | Process for the preparation of aliskiren |
WO2013124868A2 (en) | 2012-02-21 | 2013-08-29 | Mylan Laboratories Limited | Solid form of aliskiren intermediate |
WO2013144979A1 (en) | 2012-03-28 | 2013-10-03 | Maylan Laboratories Ltd | Process for the preparation of aliskiren |
WO2013171767A1 (en) | 2012-05-18 | 2013-11-21 | Mylan Laboratories Limited | An improved process for the preparation of aliskiren |
CN104876832B (zh) * | 2014-02-28 | 2016-12-07 | 华润双鹤药业股份有限公司 | 阿利吉仑的4-位差向异构体、其制备方法及用途 |
CN106146339B (zh) * | 2015-04-23 | 2018-02-23 | 华润双鹤药业股份有限公司 | 阿利吉仑的5‑位差向异构体、其制备方法及用途 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4492799A (en) * | 1979-07-02 | 1985-01-08 | Union Carbide Corporation | Halo-4-alkenoic acids and their use as pesticidal intermediates |
FR2666757B1 (fr) * | 1990-09-14 | 1992-12-18 | Usinor Sacilor | Virole pour cylindre de coulee continue des metaux, notamment de l'acier, entre cylindres ou sur un cylindre. |
MY119161A (en) * | 1994-04-18 | 2005-04-30 | Novartis Ag | Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities |
US5606078A (en) | 1994-04-18 | 1997-02-25 | Ciba-Geigy Corporation | 3,5-Disubstituted tetrahydrofuran-2-ones |
US5659065A (en) * | 1994-04-18 | 1997-08-19 | Novartis Corporation | Alpha-aminoalkanoic acids and reduction products |
WO1996002340A1 (de) * | 1994-07-18 | 1996-02-01 | Siemens Aktiengesellschaft | Giesswalzen-verschleissschutzschicht |
WO1998052706A1 (de) * | 1997-05-23 | 1998-11-26 | Voest-Alpine Industrieanlagenbau Gmbh | Giesswalze für eine dünnband-stranggiessanlage |
ES2218173T3 (es) * | 1999-07-29 | 2004-11-16 | Speedel Pharma Ag | Acidos 2-alquil-5-halogano-pent-4-enocarboxilicos y su fabricacion. |
-
2001
- 2001-06-26 ES ES01940047T patent/ES2322547T3/es not_active Expired - Lifetime
- 2001-06-26 AU AU2001273763A patent/AU2001273763B2/en not_active Ceased
- 2001-06-26 WO PCT/CH2001/000399 patent/WO2002002508A1/en active Application Filing
- 2001-06-26 NZ NZ523088A patent/NZ523088A/en not_active IP Right Cessation
- 2001-06-26 US US10/312,987 patent/US6730798B2/en not_active Expired - Lifetime
- 2001-06-26 DE DE60138099T patent/DE60138099D1/de not_active Expired - Lifetime
- 2001-06-26 CN CNB018122817A patent/CN100482636C/zh not_active Expired - Lifetime
- 2001-06-26 JP JP2002507765A patent/JP4900755B2/ja not_active Expired - Lifetime
- 2001-06-26 AT AT01940047T patent/ATE426592T1/de active
- 2001-06-26 HU HU0301463A patent/HU228526B1/hu not_active IP Right Cessation
- 2001-06-26 CA CA002414847A patent/CA2414847C/en not_active Expired - Fee Related
- 2001-06-26 KR KR1020027017207A patent/KR100690471B1/ko active IP Right Grant
- 2001-06-26 IL IL15371701A patent/IL153717A0/xx unknown
- 2001-06-26 PL PL358887A patent/PL212898B1/pl unknown
- 2001-06-26 EP EP01940047A patent/EP1296935B1/en not_active Expired - Lifetime
- 2001-06-26 PT PT01940047T patent/PT1296935E/pt unknown
- 2001-06-26 AU AU7376301A patent/AU7376301A/xx active Pending
- 2001-06-26 BR BRPI0112362-9B1A patent/BR0112362B1/pt not_active IP Right Cessation
- 2001-06-26 MX MXPA02012628A patent/MXPA02012628A/es active IP Right Grant
- 2001-06-26 DK DK01940047T patent/DK1296935T3/da active
- 2001-06-29 TW TW090115929A patent/TWI289551B/zh not_active IP Right Cessation
- 2001-07-04 AR ARP010103194A patent/AR029564A1/es active IP Right Grant
-
2002
- 2002-12-27 IL IL153717A patent/IL153717A/en not_active IP Right Cessation
-
2003
- 2003-01-02 NO NO20030012A patent/NO328105B1/no not_active IP Right Cessation
-
2006
- 2006-12-19 HK HK06113953.2A patent/HK1093201A1/xx not_active IP Right Cessation
-
2007
- 2007-11-29 IL IL187795A patent/IL187795A/en not_active IP Right Cessation
- 2007-11-29 IL IL187796A patent/IL187796A/en not_active IP Right Cessation
-
2009
- 2009-05-28 CY CY20091100571T patent/CY1109110T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100690471B1 (ko) | 치환된 옥타노일 아미드의 제조방법 | |
US6800769B2 (en) | Process for the preparation of substituted octanoyl amides | |
AU2001273763A1 (en) | Process for the preparation of substituted octanoyl amides | |
EP1200390B1 (de) | Herstellung von n-substituierten 2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoylamiden | |
EP2189442B1 (en) | Process and intermediates for the preparation of aliskiren | |
US20080146819A1 (en) | Process for Preparing Levetiracetam | |
US5461157A (en) | Process for preparing pyrrolidinylacetamide derivatives | |
KR940009527B1 (ko) | 2-(2'-아미노티아졸-4'-일)-2-(치환옥시이미노)아세테이트의 제조방법 | |
ZA200300018B (en) | Process for the preparation of substituted octanoyl amides. | |
JPS61254544A (ja) | 4,4,4−トリフルオロバリン系化合物の製造法 | |
JPH06247961A (ja) | パントテン酸アセトナイドの製造方法 | |
JPH09255645A (ja) | 1−アジドインダン−2−オール誘導体 | |
BE504403A (ko) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130201 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140204 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150130 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160127 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20170725 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20180201 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20190129 Year of fee payment: 13 |